[go: up one dir, main page]

NO20043586L - Fremgangsmate for fremstilling av organiske forbindelser - Google Patents

Fremgangsmate for fremstilling av organiske forbindelser

Info

Publication number
NO20043586L
NO20043586L NO20043586A NO20043586A NO20043586L NO 20043586 L NO20043586 L NO 20043586L NO 20043586 A NO20043586 A NO 20043586A NO 20043586 A NO20043586 A NO 20043586A NO 20043586 L NO20043586 L NO 20043586L
Authority
NO
Norway
Prior art keywords
preparation
organic compounds
compounds
organic
Prior art date
Application number
NO20043586A
Other languages
English (en)
Other versions
NO327363B1 (no
Inventor
Prasad Koteswara Kapa
Ulrich Beutler
Werner Zaugg
Eric M Loeser
Guang-Pei Chen
Michael J Girgis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20043586L publication Critical patent/NO20043586L/no
Publication of NO327363B1 publication Critical patent/NO327363B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Quinoline Compounds (AREA)
NO20043586A 2002-01-28 2004-08-27 Fremgangsmate for fremstilling av organiske forbindelser NO327363B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35231602P 2002-01-28 2002-01-28
US38318802P 2002-05-24 2002-05-24
PCT/EP2003/000804 WO2003064382A2 (en) 2002-01-28 2003-01-27 Process for the manufacture of organic compounds

Publications (2)

Publication Number Publication Date
NO20043586L true NO20043586L (no) 2004-10-07
NO327363B1 NO327363B1 (no) 2009-06-15

Family

ID=27669055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043586A NO327363B1 (no) 2002-01-28 2004-08-27 Fremgangsmate for fremstilling av organiske forbindelser

Country Status (19)

Country Link
US (3) US6835838B2 (no)
EP (1) EP1472227B1 (no)
JP (1) JP2005516064A (no)
KR (2) KR20040077883A (no)
CN (2) CN1625550A (no)
AU (4) AU2003239294B2 (no)
BR (1) BR0307236A (no)
CA (1) CA2472340A1 (no)
CO (1) CO5601045A2 (no)
EC (1) ECSP045202A (no)
IL (1) IL162817A0 (no)
MX (1) MXPA04007308A (no)
NO (1) NO327363B1 (no)
NZ (3) NZ554366A (no)
PL (1) PL371383A1 (no)
RU (1) RU2360903C2 (no)
SG (2) SG157225A1 (no)
WO (1) WO2003064382A2 (no)
ZA (1) ZA200405239B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100888408B1 (ko) 2001-07-13 2009-03-13 아스트라제네카 유케이 리미티드 아미노피리미딘 화합물의 제조 방법
TWI243165B (en) * 2001-11-14 2005-11-11 Nissan Chemical Ind Ltd Process for producing optically active oxoheptenoic acid ester
MXPA04007396A (es) * 2002-01-31 2004-10-11 Novartis Ag Proceso para la elaboracion de inhibidores de reductasa hmg-coa.
US7339062B2 (en) * 2002-09-20 2008-03-04 Nissan Chemical Industries, Ltd. Method for producing a 3,5-dihydroxy-6-heptenoate
CN101219992B (zh) * 2003-02-12 2011-08-31 日产化学工业株式会社 匹伐他汀钙的晶形
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN1763015B (zh) * 2004-10-22 2011-06-22 四川抗菌素工业研究所有限公司 一种罗舒伐他汀及其药用盐的制备方法及中间体
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
SI2024341T1 (sl) * 2006-05-03 2016-04-29 Msn Laboratories Private Limited Novi postopek za statine in njihove farmacevtsko sprejemljive soli
WO2008044243A2 (en) * 2006-10-09 2008-04-17 Manne Satyanarayana Reddy Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
EP2387561A4 (en) * 2009-01-19 2012-07-25 Msn Lab Ltd IMPROVED PROCESS FOR THE PREPARATION OF HIGH-PURITY (3R, 5S) -7-β-CYCLOPROPYL-4- (4-FLUOROPHENYL) QUINOLIN-3-YL-3,5-DIHYDROXY-6 (E) -HEPTENOIC ACID, INCLUDING ITS PHARMACEUTICALLY ACCEPTABLE SALTS
RU2425034C1 (ru) * 2010-01-11 2011-07-27 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") Способ получения производных (e)-4-(6,7-диметокси-2-метил-3-хинолил)-3-бутен-2-она
US8987444B2 (en) 2010-01-18 2015-03-24 Msn Laboratories Private Limited Process for the preparation of amide intermediates and their use thereof
EP2423195A1 (en) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
JP2013536219A (ja) * 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
EP2638013A4 (en) * 2010-11-12 2014-03-26 Hetero Research Foundation NEW POLYMORPHS OF CALCIUM PIVASTATIN
WO2012140490A2 (en) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Process for preparing quinoline derivative
CN103755568B (zh) * 2013-12-10 2015-10-28 江西科技师范大学 IeodomycinA和B立体选择性合成方法
JP6704916B2 (ja) * 2015-08-05 2020-06-03 株式会社エーピーアイ コーポレーション ピタバスタチンカルシウムの製造方法
CN108976168B (zh) * 2017-06-02 2020-09-25 浙江京新药业股份有限公司 一种匹伐他汀半钙盐晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906624A (en) * 1987-09-08 1990-03-06 Warner-Lambert Company 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
NZ230121A (en) * 1988-08-29 1993-08-26 Squibb & Sons Inc Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels
JP3528186B2 (ja) * 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3130342B2 (ja) * 1991-10-04 2001-01-31 日産化学工業株式会社 動脈硬化性血管内膜肥厚抑制薬
JP3554036B2 (ja) * 1994-09-06 2004-08-11 宇部興産株式会社 光学活性な7−置換キノリル−3,5−ジヒドロキシ−ヘプト−6−エン酸エステル誘導体の製造方法
TWI243165B (en) * 2001-11-14 2005-11-11 Nissan Chemical Ind Ltd Process for producing optically active oxoheptenoic acid ester
WO2008096257A1 (en) * 2007-02-08 2008-08-14 Aurobindo Pharma Limited An improved process for preparation of rosuvastatin calcium

Also Published As

Publication number Publication date
CN1660818A (zh) 2005-08-31
ECSP045202A (es) 2004-09-28
US20030208072A1 (en) 2003-11-06
WO2003064382A2 (en) 2003-08-07
CN100378081C (zh) 2008-04-02
NZ554367A (en) 2008-11-28
NZ534136A (en) 2007-08-31
KR20100091267A (ko) 2010-08-18
US7572917B2 (en) 2009-08-11
CN1625550A (zh) 2005-06-08
EP1472227A2 (en) 2004-11-03
EP1472227B1 (en) 2016-04-27
IL162817A0 (en) 2005-11-20
JP2005516064A (ja) 2005-06-02
MXPA04007308A (es) 2004-10-29
RU2004126448A (ru) 2005-06-27
US6835838B2 (en) 2004-12-28
AU2006225206B2 (en) 2009-08-06
KR20040077883A (ko) 2004-09-07
SG161742A1 (en) 2010-06-29
AU2006225205A1 (en) 2006-10-26
CA2472340A1 (en) 2003-08-07
ZA200405239B (en) 2005-07-27
NZ554366A (en) 2008-11-28
US20090299065A1 (en) 2009-12-03
PL371383A1 (en) 2005-06-13
US20040249154A1 (en) 2004-12-09
AU2003239294B2 (en) 2006-10-19
AU2009208129A1 (en) 2009-09-03
CO5601045A2 (es) 2006-01-31
BR0307236A (pt) 2004-12-07
RU2360903C2 (ru) 2009-07-10
SG157225A1 (en) 2009-12-29
AU2006225206A1 (en) 2006-10-26
NO327363B1 (no) 2009-06-15
WO2003064382A3 (en) 2003-12-11
AU2006225205B2 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
EG24716A (en) Combination of organic compounds
GB0222056D0 (en) Process for the manufacture of organic compounds
GB0212412D0 (en) Combination of organic compounds
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
GB0204129D0 (en) Process for the manufacture of organic compounds
GB0316546D0 (en) Process for the manufacture of organic compounds
IS8470A (is) Notkun lífrænna efnasambanda
NO20052568D0 (no) Fremgangsmate for fremstilling av makrolidforbindelse
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20033408D0 (no) Fremgangsmåte for fremstilling av krystallinske nanopartikler
GB0210234D0 (en) Process for the manufacture of organic compounds
NO20034003L (no) Fremgangsmåte for fremstilling av imidazolforbindelser
NO20052158L (no) Fremgangsmate for fremstilling av en benzimidazolforbindelse.
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
NO20034597D0 (no) Fremgangsmåte for fremstilling av cantaxantin
GB0402262D0 (en) Process for the manufacture of organic compounds
IL172629A0 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20043455L (no) Fremgangsmate for fremstilling av 7alfa-metylsteroider

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees